Enabling patients with autoimmune diseases to reimagine life

iStock-1131857558-home

Our Mission

To lead the development and commercialization of transformative immunology-based therapies for patients in need.

Learn More

Our Pipeline

Advancing clinical-stage programs for multiple autoimmune diseases.

Learn More

Latest News

July 1, 2024

Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer

Read More

May 7, 2024

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs

Read More
long-arrow-right-regularfacebook-brandsfacebook-f-brandsinstagram-brandslinkedin-brandslinkedin-in-brandssubmit-arrowtwitter-brandstwitter-square-brandsyoutube-brands